Alnylam Pharmaceuticals Change in Accounts Receivable 2010-2025 | ALNY
Alnylam Pharmaceuticals change in accounts receivable for the twelve months ending March 31, 2025 was $-0.111B, a 31.98% decline year-over-year.
- Alnylam Pharmaceuticals annual change in accounts receivable for 2024 was $-0.087B, a 1.58% decline from 2023.
- Alnylam Pharmaceuticals annual change in accounts receivable for 2023 was $-0.088B, a 92.86% increase from 2022.
- Alnylam Pharmaceuticals annual change in accounts receivable for 2022 was $-0.046B, a 55.21% decline from 2021.